{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T19:45:27Z","timestamp":1793994327422,"version":"4.8.0"},"reference-count":45,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2024,8,1]]},"abstract":"Importance<\/jats:title>Pediatric oncology patients are increasingly recognized as having an underlying cancer predisposition syndrome (CPS). Surveillance is often recommended to detect new tumors at their earliest and most curable stages. Data on the effectiveness and outcomes of surveillance for children with CPS are limited.<\/jats:p><\/jats:sec>Objective<\/jats:title>To evaluate the performance of surveillance across a wide spectrum of CPSs.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This cohort study reviewed surveillance outcomes for children and young adults from birth to age 23 years with a clinical and\/or molecular CPS diagnosis from January 1, 2009, through September 31, 2021. Patients were monitored using standard surveillance regimens for their corresponding CPS at a specialty pediatric oncology center. Patients with hereditary retinoblastoma and bone marrow failure syndromes were excluded. Data were analyzed between August 1, 2021, and December 6, 2023.<\/jats:p><\/jats:sec>Exposure<\/jats:title>Cancer predisposition syndrome.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Outcomes of surveillance were reviewed to evaluate the incidence, spectrum, and clinical course of newly detected tumors. Surveillance modalities were classified for accuracy and assessed for common strengths and weaknesses.<\/jats:p><\/jats:sec>Results<\/jats:title>A total of 274 children and young adults (mean age, 8 years [range, birth to 23 years]; 144 female [52.6%]) with 35 different CPSs were included, with a median follow-up of 3 years (range, 1 month to 12 years). During the study period, 35 asymptomatic tumors were detected in 27 patients through surveillance (9.9% of the cohort), while 5 symptomatic tumors were detected in 5 patients (1.8% of the cohort) outside of surveillance, 2 of whom also had tumors detected through surveillance. Ten of the 35 tumors (28.6%) were identified on first surveillance imaging. Malignant solid and brain tumors identified through surveillance were more often localized (20 of 24 [83.3%]) than similar tumors detected before CPS diagnosis (71 of 125 [56.8%]; P<\/jats:italic>\u2009&amp;lt;\u2009.001). Of the 24 tumors identified through surveillance and surgically resected, 17 (70.8%) had completely negative margins. When analyzed across all imaging modalities, the sensitivity (96.4%), specificity (99.6%), positive predictive value (94.3%), and negative predictive value (99.6%) of surveillance were high, with few false-positive (6 [0.4%]) or false-negative (5 [0.3%]) findings.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>These findings suggest that standardized surveillance enables early detection of new tumors across a wide spectrum of CPSs, allowing for complete surgical resection and successful treatment in the majority of patients.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamaoncol.2024.1878","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T15:02:22Z","timestamp":1718895742000},"page":"1060","source":"Crossref","is-referenced-by-count":19,"title":["Performance of Tumor Surveillance for Children With Cancer Predisposition"],"prefix":"10.1001","volume":"10","author":[{"given":"Alise","family":"Blake","sequence":"first","affiliation":[{"name":"Department of Oncology, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa R.","family":"Perrino","sequence":"additional","affiliation":[{"name":"Department of Oncology, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara E.","family":"Morin","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Imaging, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"},{"name":"Now with Department of Radiology, Cincinnati Children\u2019s Hospital Medical Center, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Taylor","sequence":"additional","affiliation":[{"name":"Department of Oncology, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose B.","family":"McGee","sequence":"additional","affiliation":[{"name":"Department of Oncology, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Lewis","sequence":"additional","affiliation":[{"name":"Department of Hematology, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy","family":"Hines-Dowell","sequence":"additional","affiliation":[{"name":"Department of Oncology, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arti","family":"Pandey","sequence":"additional","affiliation":[{"name":"Department of Oncology, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige","family":"Turner","sequence":"additional","affiliation":[{"name":"Department of Oncology, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Kubal","sequence":"additional","affiliation":[{"name":"Department of Oncology, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Howell","sequence":"additional","affiliation":[{"name":"Department of Oncology, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn W.","family":"Harrison","sequence":"additional","affiliation":[{"name":"Department of Oncology, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Abramson","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Imaging, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Schechter","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Imaging, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah D.","family":"Sabin","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Imaging, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim E.","family":"Nichols","sequence":"additional","affiliation":[{"name":"Department of Oncology, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"coi240023r1","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/s43018-021-00172-1","article-title":"Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors.","volume":"2","author":"Fiala","year":"2021","journal-title":"Nat Cancer"},{"issue":"9","key":"coi240023r2","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1001\/jama.2015.10080","article-title":"Integrative clinical sequencing in the management of refractory or relapsed cancer in youth.","volume":"314","author":"Mody","year":"2015","journal-title":"JAMA"},{"issue":"12","key":"coi240023r3","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.1158\/2159-8290.CD-20-1631","article-title":"Genomes for kids: the scope of pathogenic mutations in pediatric cancer revealed by comprehensive DNA and RNA sequencing.","volume":"11","author":"Newman","year":"2021","journal-title":"Cancer Discov"},{"issue":"5","key":"coi240023r4","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1001\/jamaoncol.2015.5699","article-title":"Diagnostic yield of clinical tumor and germline whole-exome sequencing for children with solid tumors.","volume":"2","author":"Parsons","year":"2016","journal-title":"JAMA Oncol"},{"issue":"24","key":"coi240023r5","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1056\/NEJMoa1508054","article-title":"Germline mutations in predisposition genes in pediatric cancer.","volume":"373","author":"Zhang","year":"2015","journal-title":"N Engl J Med"},{"issue":"15","key":"coi240023r6","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1158\/1078-0432.CCR-15-2717","article-title":"Multidimensional clinomics for precision therapy of children and adolescent young adults with relapsed and refractory cancer: a report from the Center for Cancer Research.","volume":"22","author":"Chang","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"7","key":"coi240023r7","doi-asserted-by":"publisher","first-page":"883","DOI":"10.2217\/fon-2015-0022","article-title":"Incorporating genetic counseling into clinical care for children and adolescents with cancer.","volume":"12","author":"Everett","year":"2016","journal-title":"Future Oncol"},{"issue":"21","key":"coi240023r8","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1158\/1078-0432.CCR-17-2026","article-title":"The future of surveillance in the context of cancer predisposition: through the murky looking glass.","volume":"23","author":"Malkin","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"3","key":"coi240023r9","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00431-010-1377-2","article-title":"Educational paper: screening in cancer predisposition syndromes: guidelines for the general pediatrician.","volume":"170","author":"Teplick","year":"2011","journal-title":"Eur J Pediatr"},{"issue":"6","key":"coi240023r10","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1097\/00003246-200006000-00079","article-title":"Tolerance, withdrawal, and physical dependency after long-term sedation and analgesia of children in the pediatric intensive care unit.","volume":"28","author":"Tobias","year":"2000","journal-title":"Crit Care Med"},{"issue":"1","key":"coi240023r11","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.v66.1","article-title":"\u201cA change in perspective\u201d: exploring the experiences of adolescents with hereditary tumor predisposition.","volume":"66","author":"Weber","year":"2019","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"coi240023r12","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1001\/archpedi.154.9.873","article-title":"Ethical issues in genetic testing of children.","volume":"154","author":"Ross","year":"2000","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"3","key":"coi240023r13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.15171\/ijhpm.2014.76","article-title":"Interrelation of preventive care benefits and shared costs under the Affordable Care Act (ACA).","volume":"3","author":"Dixon","year":"2014","journal-title":"Int J Health Policy Manag"},{"issue":"19","key":"coi240023r14","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1002\/cncr.v120.19","article-title":"Impact of state-specific Medicaid reimbursement and eligibility policies on receipt of cancer screening.","volume":"120","author":"Halpern","year":"2014","journal-title":"Cancer"},{"issue":"9","key":"coi240023r15","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/S1470-2045(16)30249-2","article-title":"Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study.","volume":"17","author":"Villani","year":"2016","journal-title":"Lancet Oncol"},{"issue":"25","key":"coi240023r16","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1200\/JCO.20.02636","article-title":"Survival benefit for individuals with constitutional mismatch repair deficiency undergoing surveillance.","volume":"39","author":"Durno","year":"2021","journal-title":"J Clin Oncol"},{"issue":"1","key":"coi240023r18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2307\/2531248","article-title":"Longitudinal data analysis for discrete and continuous outcomes.","volume":"42","author":"Zeger","year":"1986","journal-title":"Biometrics"},{"issue":"6","key":"coi240023r19","doi-asserted-by":"publisher","first-page":"e848","DOI":"10.1200\/OP.22.00677","article-title":"Cascade genetic risk education and testing in families with hereditary cancer syndromes: a pilot study.","volume":"19","author":"Katz","year":"2023","journal-title":"JCO Oncol Pract"},{"issue":"9","key":"coi240023r20","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1111\/jog.v46.9","article-title":"Mechanisms to increase cascade testing in hereditary breast and ovarian cancer: impact of introducing standardized communication aids into genetic counseling.","volume":"46","author":"Garcia","year":"2020","journal-title":"J Obstet Gynaecol Res"},{"issue":"11","key":"coi240023r21","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1158\/1078-0432.CCR-17-0702","article-title":"Pediatric cancer predisposition and surveillance: an overview, and a tribute to Alfred G. Knudson Jr.","volume":"23","author":"Brodeur","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"10","key":"coi240023r22","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1158\/1078-0432.CCR-17-3089","article-title":"DICER1 and associated conditions: identification of at-risk individuals and recommended surveillance strategies.","volume":"24","author":"Schultz","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"5","key":"coi240023r23","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.ejca.2013.12.005","article-title":"Genetic and clinical determinants of constitutional mismatch repair deficiency syndrome: report from the constitutional mismatch repair deficiency consortium.","volume":"50","author":"Bakry","year":"2014","journal-title":"Eur J Cancer"},{"issue":"8","key":"coi240023r24","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.ejca.2015.02.008","article-title":"Phenotypic and genotypic characterisation of biallelic mismatch repair deficiency (BMMR-D) syndrome.","volume":"51","author":"Durno","year":"2015","journal-title":"Eur J Cancer"},{"issue":"8","key":"coi240023r25","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1002\/hep4.1972","article-title":"Molecular networks of hepatoblastoma predisposition and oncogenesis in Beckwith-Wiedemann syndrome.","volume":"6","author":"Sobel Naveh","year":"2022","journal-title":"Hepatol Commun"},{"issue":"4","key":"coi240023r26","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1002\/pbc.v50:4","article-title":"Pediatric thyroid cancer arising after treatment for pleuropulmonary blastoma.","volume":"50","author":"Oue","year":"2008","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"coi240023r27","doi-asserted-by":"publisher","first-page":"E1072","DOI":"10.1210\/jc.2013-4206","article-title":"Exploring the association between DICER1 mutations and differentiated thyroid carcinoma.","volume":"99","author":"de Kock","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"coi240023r28","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1158\/1078-0432.CCR-17-0515","article-title":"Pediatric cancer predisposition imaging: focus on whole-body MRI.","volume":"23","author":"Greer","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"2","key":"coi240023r29","doi-asserted-by":"publisher","first-page":"400","DOI":"10.2214\/AJR.14.13663","article-title":"Diagnostic performance of whole-body MRI as a tool for cancer screening in children with genetic cancer-predisposing conditions.","volume":"205","author":"Anupindi","year":"2015","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"coi240023r30","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nrendo.2017.166","article-title":"Expert consensus document: clinical and molecular diagnosis, screening and management of Beckwith-Wiedemann syndrome: an international consensus statement.","volume":"14","author":"Brioude","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"13","key":"coi240023r31","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1158\/1078-0432.CCR-17-0710","article-title":"Surveillance recommendations for children with overgrowth syndromes and predisposition to Wilms tumors and hepatoblastoma.","volume":"23","author":"Kalish","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"11","key":"coi240023r32","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1158\/1078-0432.CCR-17-0428","article-title":"Recommendations for surveillance for children with leukemia-predisposing conditions.","volume":"23","author":"Porter","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"11","key":"coi240023r33","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1158\/1078-0432.CCR-17-0574","article-title":"Clinical management and tumor surveillance recommendations of inherited mismatch repair deficiency in childhood.","volume":"23","author":"Tabori","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"13","key":"coi240023r34","doi-asserted-by":"publisher","first-page":"e107","DOI":"10.1158\/1078-0432.CCR-17-0790","article-title":"Cancer screening recommendations and clinical management of inherited gastrointestinal cancer syndromes in childhood.","volume":"23","author":"Achatz","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"2","key":"coi240023r35","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1530\/eje.1.02085","article-title":"Prepubertal gynecomastia in Peutz-Jeghers syndrome: incomplete penetrance in a familial case and management with an aromatase inhibitor.","volume":"154","author":"Lefevre","year":"2006","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"coi240023r36","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/ajg.2014.435","article-title":"ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes.","volume":"110","author":"Syngal","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"coi240023r37","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/sj.bjc.6605997","article-title":"Evaluation of management of desmoid tumours associated with familial adenomatous polyposis in Dutch patients.","volume":"104","author":"Nieuwenhuis","year":"2011","journal-title":"Br J Cancer"},{"issue":"11","key":"coi240023r38","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1111\/codi.2011.13.issue-11","article-title":"Risk factors predicting desmoid occurrence in patients with familial adenomatous polyposis: a meta-analysis.","volume":"13","author":"Sinha","year":"2011","journal-title":"Colorectal Dis"},{"issue":"5","key":"coi240023r39","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1007\/s10897-017-0091-x","article-title":"Should genetic testing be offered for children? the perspectives of adolescents and emerging adults in families with Li-Fraumeni Syndrome.","volume":"26","author":"Alderfer","year":"2017","journal-title":"J Genet Couns"},{"issue":"5","key":"coi240023r40","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-043215","article-title":"Scanxiety: a scoping review about scan-associated anxiety.","volume":"11","author":"Bui","year":"2021","journal-title":"BMJ Open"},{"key":"coi240023r41","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2022.100265","article-title":"Cancer surveillance for patients with Li-Fraumeni syndrome in Brazil: a cost-effectiveness analysis.","volume":"12","author":"Frankenthal","year":"2022","journal-title":"Lancet Reg Health Am"},{"issue":"5","key":"coi240023r42","doi-asserted-by":"publisher","first-page":"664","DOI":"10.2967\/jnumed.120.261891","article-title":"11C-methionine PET for identification of pediatric high-grade glioma recurrence.","volume":"63","author":"Bag","year":"2022","journal-title":"J Nucl Med"},{"issue":"8","key":"coi240023r43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003734","article-title":"Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: a cross-sectional study.","volume":"18","author":"Szymanski","year":"2021","journal-title":"PLoS Med"},{"issue":"10","key":"coi240023r44","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1038\/s41416-021-01498-4","article-title":"Estimating the population health impact of a multi-cancer early detection genomic blood test to complement existing screening in the US and UK.","volume":"125","author":"Hackshaw","year":"2021","journal-title":"Br J Cancer"},{"issue":"403","key":"coi240023r45","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aan2415","article-title":"Direct detection of early-stage cancers using circulating tumor DNA.","volume":"9","author":"Phallen","year":"2017","journal-title":"Sci Transl Med"},{"key":"coi240023r17","volume-title":"AJCC Cancer Staging Manual","author":"Amin","year":"2017","edition":"8th ed"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2820215\/jamaoncology_blake_2024_oi_240023_1723659878.91173.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T15:02:25Z","timestamp":1723734145000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2820215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,1]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2024.1878","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,1]]}}}